Cooper Net Current Debt 2010-2025 | COO
Cooper annual/quarterly net current debt history and growth rate from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
- Cooper net current debt for the quarter ending July 31, 2025 was $0.012B, a 450% decline year-over-year.
- Cooper net current debt for the twelve months ending July 31, 2025 was $0.039B, a 111.03% decline year-over-year.
- Cooper annual net current debt for 2024 was $-0.012B, a 96.64% decline from 2023.
- Cooper annual net current debt for 2023 was $-0.351B, a 206.62% decline from 2022.
- Cooper annual net current debt for 2022 was $0.329B, a 202.49% decline from 2021.
Cooper Annual Net Current Debt
(Millions of US $) |
| 2024 |
$-12 |
| 2023 |
$-351 |
| 2022 |
$329 |
| 2021 |
$-321 |
| 2020 |
$-5 |
| 2019 |
$525 |
| 2018 |
$14 |
| 2017 |
$-212 |
| 2016 |
$-132 |
| 2015 |
$134 |
| 2014 |
$-7 |
| 2013 |
$21 |
| 2012 |
$-64 |
| 2011 |
$21 |
| 2010 |
$12 |
| 2009 |
$-36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$13.399B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
